Debevoise on Sawai’s $1.05 bln buy of Upsher-Smith's generic-drugs unit
BY John Kang, Reuters |
Debevoise & Plimpton has represented Japan’s Sawai Pharmaceutical in a $1.05 billion to purchase the generic-drug unit of Minnesota-based Upsher-Smith Laboratories, which turned to U.S. firm Lindquist & Vennum for advice.